Leila Njimoluh
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Lipoproteins and Cardiovascular Health, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → A Proprotein Convertase Subtilisin-like/Kexin Type 9 (PCSK9) C-terminal Domain Antibody Antigen-binding Fragment Inhibits PCSK9 Internalization and Restores Low Density Lipoprotein Uptake(2010)107 cited
- Abstract 1318: A PCSK9 C-terminal Domain Binding Fab Inhibits PCSK9 Internalization and Restores LDL-uptake(2009)